Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2021

Oct 1, 2021

30587_dirs_2021-10-01_8e13f904-fcc7-45fa-98ee-de429162f72a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2021-10-01

Reporting Person: SVF Investments (UK) Ltd (10% Owner)
Reporting Person: SoftBank Vision Fund L.P. (10% Owner)
Reporting Person: SVF GP (Jersey) Ltd (10% Owner)
Reporting Person: SVF Holdings (UK) LLP (10% Owner)
Reporting Person: SB INVESTMENT ADVISERS (UK) LTD (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 99375586 Indirect

Footnotes

F1: Securities held of record by SVF Investments (UK) Limited. SVF GP (Jersey) Limited is the general partner of Softbank Vision Fund LP, which is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments (UK) Limited. SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed by SVF GP (Jersey) Limited as the alternative investment fund manager ("AIFM") of SoftBank Vision Fund LP. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund LP's investments.